Treatment of Severe Nausea and Vomiting in Pregnancy
For severe nausea and vomiting in pregnancy (NVP), a stepwise approach should be implemented, starting with non-pharmacological methods, followed by first-line medications (vitamin B6 with doxylamine), then second-line medications (metoclopramide or ondansetron), and finally IV hydration and corticosteroids for refractory cases. 1
Assessment of Severity
Use the Pregnancy-Unique Quantification of Emesis (PUQE) score to assess severity:
- Mild (≤6 points)
- Moderate (7-12 points)
- Severe (≥13 points)
Evaluate for signs of hyperemesis gravidarum:
- Dehydration
- Weight loss >5% of pre-pregnancy weight
- Electrolyte imbalances
- Ketonuria
Treatment Algorithm
Step 1: Non-pharmacological Approaches
- Dietary modifications:
- Small, frequent, bland meals
- High-protein, low-fat meals
- Avoid spicy, fatty, acidic, and fried foods
- BRAT diet (bananas, rice, applesauce, toast)
- Lifestyle adjustments:
- Identify and avoid specific triggers (strong odors, activities)
- Stay hydrated with small, frequent sips of fluid
- Ginger 250 mg capsules 4 times daily 1
Step 2: First-line Medications
- Vitamin B6 (pyridoxine) 10-25 mg every 8 hours, alone or with:
- Doxylamine 10-20 mg at bedtime or every 8 hours 1
Step 3: Second-line Medications (for moderate to severe cases)
- Metoclopramide 5-10 mg every 8 hours (safe in pregnancy with no significant increase in risk of major congenital defects) 1
- Ondansetron 4-8 mg every 8 hours (use with caution in early first trimester due to small absolute risk increase for orofacial clefts and ventricular septal defects) 1
- H1-receptor antagonists such as promethazine or dimenhydrinate 1
Step 4: Refractory Cases
- Hospitalization criteria:
- Dehydration
- Weight loss >5% of pre-pregnancy weight
- Electrolyte imbalances
- IV fluid and electrolyte replacement
- IV thiamine supplementation (100 mg daily for minimum 7 days, followed by 50 mg daily until adequate oral intake) 1
- IV antiemetics (ondansetron or metoclopramide)
- Corticosteroids (methylprednisolone or prednisolone) for refractory cases, but avoid before 10 weeks gestation due to increased risk of oral clefts 1
Important Considerations
- Early treatment is critical to prevent progression to hyperemesis gravidarum, which affects 0.3-2% of pregnant women 1
- Hyperemesis gravidarum is characterized by prolonged and severe nausea and vomiting, dehydration, ketosis, and bodyweight loss 2
- Untreated severe hyperemesis can lead to serious complications including Wernicke's encephalopathy and central pontine myelinolysis 2
- Consider H2 blockers or proton pump inhibitors to prevent dyspepsia, which can mimic nausea 3
Common Pitfalls to Avoid
- Delaying treatment due to unfounded concerns about medication safety 1
- Using medications with limited safety data in pregnancy:
- NK-1 antagonists like aprepitant (limited human data)
- Second-generation antipsychotics like olanzapine (linked to increased risk for ventricular and septal defects) 1
- Failing to recognize hyperemesis gravidarum requiring hospitalization 1
- Minimizing symptoms as just "morning sickness" leading to undertreatment 4, 5
By following this stepwise approach and recognizing the importance of early intervention, most cases of severe nausea and vomiting in pregnancy can be effectively managed, improving maternal quality of life and preventing serious complications.